An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.
about
Innate Immunity and Biomaterials at the Nexus: Friends or FoesPyoderma gangrenosum: challenges and solutionsA Proposal for a Study on Treatment Selection and Lifestyle Recommendations in Chronic Inflammatory Diseases: A Danish Multidisciplinary Collaboration on Prognostic Factors and Personalised Medicine.Th17 can regulate silica-induced lung inflammation through an IL-1β-dependent mechanismInterleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesAn expanding role for interleukin-1 blockade from gout to cancer.A group A Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune responseIL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac AllograftsReduction of IL-17A might suppress the Th1 response and promote the Th2 response by boosting the function of Treg cells during silica-induced inflammatory response in vitro.Treating inflammation by blocking interleukin-1 in humans.Drug management of neutrophilic dermatoses.An Update on Medical Treatment Options for Hidradenitis Suppurativa.Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation.Pyoderma gangrenosum-a novel approach?Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFκB activation.A Comprehensive Review of Neutrophilic Diseases.Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts.Novel Therapeutic Approaches to Atopic Dermatitis.Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice.Anakinra Therapy for Non-cancer Inflammatory Diseases
P2860
Q26801604-7C7044F8-BAEA-4FDB-8869-7724D1922EFFQ26827982-E773F0EB-E621-43E3-B464-D9CF60A50629Q33749513-A01017D1-692E-4F37-9BDE-1679C534312AQ34336840-282A07FB-DA51-49F1-A90E-82F16E6155BEQ35133812-D9800582-20E8-4043-B4FA-344A8D39169EQ35219001-48AA50B7-D652-46A5-B132-E4B8795D5554Q35677468-3EBD9881-27EC-49D7-A0E9-E9B14086765BQ36655827-DF3B7E92-AA03-4D90-A4F5-0BFAB3301277Q37622871-0B1602F3-0413-4542-B3FB-759E657C9C19Q37636664-56CD3395-11B9-4873-991F-3658CEB59129Q38656412-7785F072-63E9-4B9C-8D1E-7325DE5666C1Q38667207-64327897-B583-4DF3-ACE4-95F385CEC981Q38815373-1CE5C0B9-BFD0-4E43-B3F8-5C1B6EE612AEQ38845130-E66F01B7-1DE4-4459-B525-96D4EE4556CFQ38973890-910DA86D-E9EC-4EC1-9D56-5C1D6EBDA516Q39422179-A62A24CB-FF73-4894-8E08-62B9077AB2B2Q41243953-E4211B15-652B-47F2-B9B8-9E01AB0E0401Q47569916-06C1CEF7-9AF7-4714-9697-64550CB404F5Q52974423-65CDF62B-0828-41E1-867C-D8B55BC901B2Q59136398-B2ADB749-D3D3-4719-8220-FBAD5A60E93B
P2860
An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@ast
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@en
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@nl
type
label
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@ast
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@en
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@nl
prefLabel
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@ast
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@en
An overview of interleukin-1 r ...... eatment of cutaneous diseases.
@nl
P1476
An overview of interleukin-1 r ...... reatment of cutaneous diseases
@en
P2093
Amir Feily
Reza Yaghoobi
P304
P356
10.2174/157488412803305821
P50
P577
2012-11-01T00:00:00Z